logo

Your current location:
Home page
>
Development
关于我们
Information
1939
In 1939 the Eighth Route Army Health Center of the Taihang Mountain Base.
1953
In 1953 Wuhan Pharmaceutical Factory began to develop insulin.
1958
In 1958 the trial production of adrenocorticotropic hormone was successful.
1960
In 1960 Dimercaptopropanol was produced exclusively in China.
1966
In 1966 Gadolinium was the first to successfully develop metronidazole.
1976
In 1976 I developed the Baibai stop eye drops exclusively for clinical use.
 
1979
In 1979  Production was officially enlarged.
1982
In 1982 Won the National Quality Silver Award.
1989
In 1989 The third-generation quinolone drug-enoxacin was approved for trial production.
1991
In 1991 It was officially approved for production.
1994
In 1994 It was renamed Wuhan Pharmaceutical Group.
1999
In 1999 Wuhan Nuojia Pharmaceutical Co., Ltd.
2002
In 2002 The company realized the "three supers" of comprehensive construction and production output, housing construction and municipal construction output plans, and the annual tax payment for the first time exceeded 10 million yuan.


Development

Copyright©2019 Wuhan Wuyao Pharmaceutical Co.,ltd

鄂ICP备11004909号   Power by 300.cn